Novavax is looking ahead to 2024, with the TGA currently assessing its submission for its updated monovalent XBB.1.5 COVID-19 vaccine and a plan to progress the development of its combination COVID-influenza vaccine.
Novavax looking to 2024 with monovalent COVID vaccine and potential combination
December 20, 2023 Latest NewsBioPharmaNews of the DayBioPharmaDispatch Executive
Latest Video
New Stories
-
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast -
New Zealand still falling behind on access to modern medicines
May 15, 2026 - - Latest News -
AusBiotech welcomes Budget's creation of new National Resilience and Science Council
May 15, 2026 - - Latest News -
Minister fired the starting gun in March, he flung the door open in Budget week
May 14, 2026 - - Latest News -
There are a number of reasons to criticise the minister on the PBS, but he is right to be annoyed about this
May 14, 2026 - - Latest News -
Long-term study finds continuing Mounjaro helps maintain weight loss
May 14, 2026 - - Latest News -
Frustrated minister encourages an early negotiation of new agreements
May 14, 2026 - - Latest News
